RHYTHM PHARMACEUTICALS, INC.
RYTM · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Meeker David P: Form 4
Insider disclosure · Filed · Report period 14 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- RYTM · 76243J105 - Common Stock, $0.001 par value per share
Company details and SEC sources
CIK 0001649904 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- RYTM on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 222 Berkeley Street, 12 Th Floor, Boston, MA, 02116
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- RHYTHM METABOLIC, INC. (to 12 Aug 2015)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields